AC
NSPR icon

Avestar Capital’s InspireMD NSPR Stock Holding History

Avestar Capital’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4K Hold
15,000
– – ﹤0.01% 508
2025
Q4 		$26.7K Hold
15,000
– – ﹤0.01% 481
2025
Q3 		$36.1K Hold
15,000
– – ﹤0.01% 476
2025
Q2 		$34K Hold
15,000
– – ﹤0.01% 489
2025
Q1 		$40.4K Hold
15,000
– – ﹤0.01% 480
2024
Q4 		$39.5K Hold
15,000
– – ﹤0.01% 516
2024
Q3 		$40.2K Sell
15,000
-5,000
-25% -$13.6K ﹤0.01% 467
2024
Q2 		$49.9K Hold
20,000
– – 0.01% 449
2024
Q1 		$47.4K Hold
20,000
– – 0.01% 456
2023
Q4 		$56.2K Hold
20,000
– – 0.01% 382
2023
Q3 		$65.4K Buy
+20,000
New +$63.9K 0.01% 357
2022
Q4 		– Sell
-10,000
Closed -$15K – 335
2022
Q3 		$15K Hold
10,000
– – ﹤0.01% 278
2022
Q2 		$20K Hold
10,000
– – ﹤0.01% 288
2022
Q1 		$32K Hold
10,000
– – 0.01% 391
2021
Q4 		$30K Buy
+10,000
New +$37.5K ﹤0.01% 422

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Avestar Capital's NSPR Position: Q1 2026 in Review

Avestar Capital held its InspireMD (NSPR) position steady in Q1 2026 at 15,000 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

Avestar Capital first reported a position in NSPR in Q4 2021 and has held it in 15 quarters since. The position peaked at $65.4K in Q3 2023. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Avestar Capital held 15,000 shares of InspireMD worth $24.4K as of Q1 2026.
  • Avestar Capital left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up ﹤0.01% of Avestar Capital's portfolio in Q1 2026, its #508 holding.
  • Avestar Capital first reported a position in InspireMD in Q4 2021 and has held it in 15 quarters since.
  • Avestar Capital's InspireMD position peaked at $65.4K in Q3 2023.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.